Chronic myeloid leukemia (CML) is a type of Philadelphia chromosome-positive (Ph+) leukemia affecting hematopoietic stem cells. Treatment and management of CML focus on improving the survival rate and quality of a patient’s life.
The improvement can be brought about with the help of advance therapeutic approaches, early diagnosis, and targeted drug therapy. Take this survey to share your opinion about the treatment and management of CML.